Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caspase 6 | 12 | 2021 | 17 | 5.020 |
Why?
|
| Caspase 9 | 8 | 2021 | 22 | 3.620 |
Why?
|
| Caspase 3 | 9 | 2021 | 104 | 2.760 |
Why?
|
| Caspases | 9 | 2021 | 164 | 2.730 |
Why?
|
| Zika Virus | 4 | 2024 | 32 | 2.430 |
Why?
|
| Caspase 7 | 8 | 2019 | 18 | 2.420 |
Why?
|
| Viral Nonstructural Proteins | 5 | 2024 | 93 | 1.940 |
Why?
|
| Green Fluorescent Proteins | 7 | 2020 | 354 | 1.900 |
Why?
|
| Apoptosis | 12 | 2021 | 1040 | 1.820 |
Why?
|
| Models, Molecular | 20 | 2019 | 1129 | 1.590 |
Why?
|
| Zika Virus Infection | 2 | 2024 | 32 | 1.460 |
Why?
|
| Allosteric Site | 6 | 2014 | 31 | 1.450 |
Why?
|
| Fluorescent Dyes | 3 | 2025 | 196 | 1.440 |
Why?
|
| Mutation, Missense | 5 | 2018 | 180 | 1.360 |
Why?
|
| Proteolysis | 6 | 2018 | 137 | 1.350 |
Why?
|
| Zinc | 3 | 2018 | 90 | 1.330 |
Why?
|
| Serine Endopeptidases | 3 | 2024 | 82 | 1.240 |
Why?
|
| Protein Structure, Secondary | 10 | 2017 | 253 | 1.160 |
Why?
|
| Peptides | 4 | 2025 | 545 | 1.150 |
Why?
|
| Flavivirus | 2 | 2024 | 8 | 1.070 |
Why?
|
| Dengue Virus | 3 | 2020 | 95 | 1.060 |
Why?
|
| Protein Conformation | 13 | 2024 | 771 | 1.060 |
Why?
|
| Neoplasm Proteins | 2 | 2018 | 276 | 1.050 |
Why?
|
| Cysteine | 2 | 2018 | 109 | 1.020 |
Why?
|
| Cysteine Endopeptidases | 2 | 2025 | 90 | 1.010 |
Why?
|
| Chikungunya virus | 1 | 2025 | 3 | 0.970 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2024 | 75 | 0.960 |
Why?
|
| Catalytic Domain | 9 | 2024 | 193 | 0.950 |
Why?
|
| Protease Inhibitors | 3 | 2024 | 103 | 0.940 |
Why?
|
| Protein Engineering | 4 | 2016 | 77 | 0.940 |
Why?
|
| Serine | 2 | 2016 | 83 | 0.920 |
Why?
|
| Molecular Probes | 2 | 2013 | 29 | 0.860 |
Why?
|
| Peptide Hydrolases | 3 | 2024 | 79 | 0.860 |
Why?
|
| Neoplasms | 3 | 2018 | 1258 | 0.850 |
Why?
|
| Disulfides | 3 | 2018 | 62 | 0.770 |
Why?
|
| Protein Binding | 11 | 2018 | 1559 | 0.760 |
Why?
|
| Crystallography, X-Ray | 8 | 2017 | 422 | 0.740 |
Why?
|
| Caspase Inhibitors | 5 | 2014 | 21 | 0.730 |
Why?
|
| Amino Acid Sequence | 11 | 2021 | 1579 | 0.710 |
Why?
|
| Binding Sites | 9 | 2019 | 870 | 0.700 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2018 | 184 | 0.680 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2017 | 121 | 0.670 |
Why?
|
| Amino Acid Substitution | 6 | 2018 | 252 | 0.660 |
Why?
|
| Neurodegenerative Diseases | 2 | 2018 | 128 | 0.630 |
Why?
|
| Eukaryotic Initiation Factor-4G | 1 | 2018 | 5 | 0.620 |
Why?
|
| Autophagy-Related Proteins | 1 | 2018 | 13 | 0.620 |
Why?
|
| Protein Folding | 2 | 2018 | 258 | 0.620 |
Why?
|
| Humans | 36 | 2025 | 59816 | 0.610 |
Why?
|
| Genes, Reporter | 3 | 2020 | 243 | 0.610 |
Why?
|
| Directed Molecular Evolution | 2 | 2016 | 10 | 0.610 |
Why?
|
| Caspase Activation and Recruitment Domain | 1 | 2018 | 2 | 0.610 |
Why?
|
| Enzyme Activation | 5 | 2021 | 353 | 0.610 |
Why?
|
| Protein Multimerization | 3 | 2018 | 167 | 0.590 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2017 | 5 | 0.590 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2018 | 89 | 0.570 |
Why?
|
| p21-Activated Kinases | 1 | 2016 | 5 | 0.550 |
Why?
|
| Allosteric Regulation | 6 | 2014 | 69 | 0.550 |
Why?
|
| Proteins | 6 | 2021 | 743 | 0.550 |
Why?
|
| Enzyme Assays | 2 | 2013 | 14 | 0.520 |
Why?
|
| Fluorescence | 2 | 2020 | 84 | 0.450 |
Why?
|
| Phosphorylation | 4 | 2018 | 860 | 0.440 |
Why?
|
| Substrate Specificity | 4 | 2025 | 323 | 0.410 |
Why?
|
| Escherichia coli | 5 | 2021 | 688 | 0.400 |
Why?
|
| Kinetics | 6 | 2020 | 735 | 0.400 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2012 | 8 | 0.390 |
Why?
|
| Proline | 1 | 2012 | 42 | 0.390 |
Why?
|
| Protein Kinases | 1 | 2012 | 139 | 0.370 |
Why?
|
| Nanocapsules | 3 | 2017 | 21 | 0.370 |
Why?
|
| Antiviral Agents | 1 | 2013 | 317 | 0.360 |
Why?
|
| Repressor Proteins | 1 | 2012 | 336 | 0.340 |
Why?
|
| Peptide Library | 1 | 2009 | 35 | 0.320 |
Why?
|
| Enzyme Stability | 3 | 2017 | 45 | 0.320 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 1975 | 0.310 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 502 | 0.290 |
Why?
|
| Nanoparticles | 3 | 2021 | 499 | 0.280 |
Why?
|
| Protein Domains | 2 | 2018 | 140 | 0.280 |
Why?
|
| Protein Structure, Tertiary | 3 | 2013 | 664 | 0.270 |
Why?
|
| Recombinant Proteins | 3 | 2013 | 696 | 0.250 |
Why?
|
| Mutation | 5 | 2016 | 2464 | 0.250 |
Why?
|
| Chikungunya Fever | 1 | 2025 | 3 | 0.240 |
Why?
|
| Sequence Analysis, Protein | 1 | 2004 | 32 | 0.240 |
Why?
|
| Cytosol | 2 | 2017 | 169 | 0.240 |
Why?
|
| Enzymes | 1 | 2004 | 33 | 0.240 |
Why?
|
| Protons | 2 | 2017 | 61 | 0.240 |
Why?
|
| Protein Structure, Quaternary | 1 | 2004 | 101 | 0.230 |
Why?
|
| Models, Chemical | 1 | 2004 | 135 | 0.230 |
Why?
|
| Catalysis | 3 | 2011 | 154 | 0.230 |
Why?
|
| Caspase 8 | 2 | 2021 | 61 | 0.220 |
Why?
|
| Drug Carriers | 2 | 2017 | 175 | 0.220 |
Why?
|
| Jurkat Cells | 3 | 2021 | 102 | 0.220 |
Why?
|
| Endosomes | 2 | 2021 | 169 | 0.190 |
Why?
|
| Salmonella | 1 | 2021 | 37 | 0.190 |
Why?
|
| Pancreatic Polypeptide | 2 | 2012 | 10 | 0.180 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2013 | 197 | 0.180 |
Why?
|
| Gels | 2 | 2017 | 62 | 0.180 |
Why?
|
| Protein Stability | 2 | 2012 | 83 | 0.180 |
Why?
|
| Flavivirus Infections | 1 | 2020 | 4 | 0.170 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 168 | 0.170 |
Why?
|
| Nanopores | 1 | 2019 | 10 | 0.170 |
Why?
|
| Enzyme Precursors | 1 | 2019 | 10 | 0.160 |
Why?
|
| Models, Biological | 1 | 2004 | 1141 | 0.160 |
Why?
|
| Porins | 1 | 2019 | 79 | 0.160 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2018 | 2 | 0.160 |
Why?
|
| Pliability | 1 | 2018 | 5 | 0.160 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2018 | 11 | 0.160 |
Why?
|
| Sulfones | 1 | 2018 | 37 | 0.160 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 376 | 0.160 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 278 | 0.160 |
Why?
|
| Hydrolysis | 1 | 2018 | 139 | 0.150 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2019 | 138 | 0.150 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 1379 | 0.150 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 310 | 0.150 |
Why?
|
| Arginine | 1 | 2018 | 113 | 0.150 |
Why?
|
| Phosphotransferases | 1 | 2017 | 21 | 0.150 |
Why?
|
| ErbB Receptors | 1 | 2018 | 113 | 0.150 |
Why?
|
| Deuterium Exchange Measurement | 1 | 2017 | 18 | 0.140 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 289 | 0.140 |
Why?
|
| Signal Transduction | 2 | 2021 | 2890 | 0.140 |
Why?
|
| Tyrosine | 1 | 2017 | 93 | 0.140 |
Why?
|
| Proteomics | 1 | 2019 | 262 | 0.140 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2017 | 21 | 0.140 |
Why?
|
| Flow Cytometry | 2 | 2016 | 638 | 0.140 |
Why?
|
| Animals | 7 | 2021 | 19719 | 0.140 |
Why?
|
| Cell Proliferation | 2 | 2021 | 942 | 0.140 |
Why?
|
| Plasmids | 2 | 2021 | 282 | 0.140 |
Why?
|
| Ligands | 3 | 2013 | 421 | 0.140 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 65 | 0.140 |
Why?
|
| Escherichia coli Proteins | 1 | 2019 | 261 | 0.140 |
Why?
|
| Polymers | 2 | 2021 | 317 | 0.130 |
Why?
|
| Lamins | 1 | 2016 | 4 | 0.130 |
Why?
|
| Biological Products | 1 | 2017 | 95 | 0.130 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 556 | 0.130 |
Why?
|
| Lipids | 1 | 2017 | 307 | 0.120 |
Why?
|
| Oxidation-Reduction | 2 | 2017 | 305 | 0.120 |
Why?
|
| Proteome | 1 | 2016 | 142 | 0.120 |
Why?
|
| Paclitaxel | 1 | 2015 | 91 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 2 | 2017 | 397 | 0.120 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 275 | 0.110 |
Why?
|
| Mutagenesis | 1 | 2014 | 130 | 0.110 |
Why?
|
| Molecular Docking Simulation | 1 | 2013 | 83 | 0.110 |
Why?
|
| Drug Discovery | 1 | 2014 | 92 | 0.100 |
Why?
|
| Molecular Weight | 1 | 2013 | 189 | 0.100 |
Why?
|
| Circular Dichroism | 1 | 2013 | 107 | 0.100 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2013 | 90 | 0.100 |
Why?
|
| Peptide Mapping | 1 | 2012 | 29 | 0.100 |
Why?
|
| Thrombin | 1 | 2012 | 25 | 0.100 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2013 | 110 | 0.100 |
Why?
|
| Mass Spectrometry | 2 | 2015 | 290 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2013 | 106 | 0.100 |
Why?
|
| Molecular Mimicry | 1 | 2012 | 35 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 256 | 0.100 |
Why?
|
| Aminoisobutyric Acids | 1 | 2012 | 9 | 0.100 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 558 | 0.100 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 59 | 0.090 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 72 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2013 | 596 | 0.090 |
Why?
|
| Apoenzymes | 1 | 2011 | 4 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 2013 | 353 | 0.090 |
Why?
|
| NIH 3T3 Cells | 1 | 2011 | 96 | 0.090 |
Why?
|
| Protein Transport | 1 | 2012 | 394 | 0.090 |
Why?
|
| HeLa Cells | 3 | 2017 | 528 | 0.080 |
Why?
|
| Computational Biology | 1 | 2012 | 331 | 0.080 |
Why?
|
| Molecular Structure | 2 | 2015 | 377 | 0.080 |
Why?
|
| Temperament | 1 | 2009 | 18 | 0.080 |
Why?
|
| Thioredoxins | 1 | 2009 | 15 | 0.080 |
Why?
|
| Protein Denaturation | 1 | 2009 | 66 | 0.080 |
Why?
|
| Isotope Labeling | 1 | 2009 | 68 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2009 | 291 | 0.080 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 385 | 0.080 |
Why?
|
| Viral Proteins | 1 | 2009 | 261 | 0.070 |
Why?
|
| Cell Death | 2 | 2020 | 272 | 0.070 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2017 | 252 | 0.060 |
Why?
|
| Amides | 1 | 2004 | 51 | 0.060 |
Why?
|
| Dimerization | 1 | 2004 | 146 | 0.060 |
Why?
|
| Mice | 2 | 2021 | 10307 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2009 | 820 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 346 | 0.050 |
Why?
|
| Colorimetry | 1 | 2022 | 26 | 0.050 |
Why?
|
| Homeostasis | 1 | 2004 | 343 | 0.050 |
Why?
|
| Bacteriolysis | 1 | 2021 | 5 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 130 | 0.050 |
Why?
|
| Salmonella typhimurium | 1 | 2021 | 80 | 0.050 |
Why?
|
| Endocytosis | 1 | 2021 | 148 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2020 | 56 | 0.040 |
Why?
|
| Dithiothreitol | 1 | 2017 | 18 | 0.040 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2017 | 82 | 0.040 |
Why?
|
| Polymerization | 1 | 2017 | 35 | 0.040 |
Why?
|
| Glutathione | 1 | 2017 | 51 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2018 | 96 | 0.040 |
Why?
|
| Liposomes | 1 | 2017 | 100 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2017 | 125 | 0.030 |
Why?
|
| Drug Design | 1 | 2018 | 144 | 0.030 |
Why?
|
| Cryoelectron Microscopy | 1 | 2017 | 185 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 454 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2015 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2015 | 132 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2015 | 133 | 0.030 |
Why?
|
| Drug Stability | 1 | 2015 | 138 | 0.030 |
Why?
|
| Emulsions | 1 | 2017 | 456 | 0.030 |
Why?
|
| Receptor, PAR-1 | 1 | 2012 | 4 | 0.030 |
Why?
|
| Databases, Protein | 1 | 2012 | 47 | 0.020 |
Why?
|
| Quantum Theory | 1 | 2012 | 8 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2013 | 274 | 0.020 |
Why?
|
| Internet | 1 | 2012 | 460 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 998 | 0.020 |
Why?
|
| Male | 1 | 2021 | 27769 | 0.010 |
Why?
|
| Female | 1 | 2021 | 31098 | 0.010 |
Why?
|